ARCA:PBE

Invesco Biotechnology & Genome ETF

$ 67.27 -0.29 ( -0.43%) 03:43 PM EST
PE Ratio:
27.27
PB Ratio:
3.82
Volume:
2.83K
Dividend Yield %:
0.1
Last Holding update 2024-09-27 30 Stocks (6 new)
Value $270.00 Mil Turnover 22 %
Top Holdings: ILMN(5.40%) GILD(5.37%) INCY(5.13%) BMRN(5.11%) VRTX(5.00%)
Portfolio Report
Registrant: Invesco Biotechnology & Genome ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Key Statistics

Name Value
Day's Open ($) 67.93
Day's Range ($) 67.11 - 67.9899
Day's Volume 2,833
52-Week Range ($) 52.47 - 72.72
Beta 0.78
Volatility 20.51
14-Day RSI 38.83
14-Day ATR ($) 0.847643
20-Day SMA ($) 69.077955

Fundamental Data

Name Value
Market Cap (Mil $) 254.281
Shares Outstanding (Mil) 3.78
PE Ratio 27.27
PE Ratio (10y Range) 14.2 - 35.8
PE Ratio (10y Median) 21.2
PB Ratio 3.82
PB Ratio (10y Range) 2.94 - 5.95
PB Ratio (10y Median) 4.16

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.065
Dividend Yield % 0.1
Dividend Yield % (10y Range) 0.01 - 1.84
Dividend Yield % (10y Median) 0.1
Next Dividend Payment Date
Dividend Frequency Quarterly

PBE Invesco Biotechnology & Genome ETF Fundamental Charts

Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF

Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF

Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF

Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF

PBE Invesco Biotechnology & Genome ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PBE

No Available Data

ARCA:PBE is held by these investors

No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2024-07-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
ILMN 		Illumina Inc
118,985
14587.560
New Holding
5.400
+5.40%
0.070
+21.58%
+4.47%
22523.427
Medical Diagnostics & Research
GILD 		Gilead Sciences Inc
190,532
14491.860
+6.09%
5.370
+0.31%
0.020
+21.92%
+13.12%
110530.396
Drug Manufacturers
INCY 		Incyte Corp
212,794
13846.510
New Holding
5.130
+5.13%
0.110
-2.50%
+3.90%
12565.092
Biotechnology
BMRN 		Biomarin Pharmaceutical Inc
163,681
13803.220
+12.18%
5.110
+0.55%
0.090
-16.83%
-27.00%
13401.047
Biotechnology
VRTX 		Vertex Pharmaceuticals Inc
27,259
13512.830
-11.38%
5.000
-0.56%
0.010
-3.85%
+15.98%
121801.010
Biotechnology
REGN 		Regeneron Pharmaceuticals Inc
12,513
13503.900
-8.43%
5.000
-0.42%
0.010
-12.44%
+5.76%
102396.854
Biotechnology
AMGN 		Amgen Inc
40,588
13494.290
-11.06%
5.000
-0.56%
0.010
-5.28%
+12.02%
169629.460
Drug Manufacturers
NBIX 		Neurocrine Biosciences Inc
86,725
12277.660
-11.08%
4.550
-0.60%
0.090
-20.81%
-12.33%
11664.776
Drug Manufacturers
IONS 		Ionis Pharmaceuticals Inc
176,538
8731.570
+10.94%
3.230
+0.32%
0.110
-23.59%
-23.36%
6114.457
Biotechnology
HALO 		Halozyme Therapeutics Inc
154,246
8523.630
-21.32%
3.160
-0.65%
0.120
-10.61%
+33.39%
6245.239
Biotechnology

Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns

Invesco Biotechnology & Genome ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
ILMN 		Illumina Inc2024-07-31New Buy
+5.40%
●
98.22 ($109.76) 125.23
$141.39
28.82%
New holding
118,985
118,985
BIIB 		Biogen Inc2024-07-31Sold Out
-5.15%
●
211.17 ($225.35) 236.8
$183.86
-18.41%
Sold Out
0
-59,022
INCY 		Incyte Corp2024-07-31New Buy
+5.13%
●
53.06 ($60.28) 68.61
$65.24
8.23%
New holding
212,794
212,794
IRWD 		Ironwood Pharmaceuticals Inc2024-07-31New Buy
+2.86%
●
5.58 ($6.58) 8.3
$3.98
-39.51%
New holding
1,130,122
1,130,122
CLDX 		Celldex Therapeutics Inc2024-07-31Sold Out
-2.79%
●
32.76 ($37.6) 44.56
$28.13
-25.19%
Sold Out
0
-183,305
TECH 		Bio-Techne Corp2024-07-31Reduce
-2.58%
●
71.24 ($77.31) 84.15
$68.37
-11.56%
Reduce -54.5%
83,707
-100,258
OPK 		OPKO Health Inc2024-07-31New Buy
+2.57%
●
1.21 ($1.33) 1.52
$1.40
5.26%
New holding
4,886,099
4,886,099
XENE 		Xenon Pharmaceuticals Inc2024-07-31Sold Out
-2.41%
●
36.12 ($39.87) 43.96
$41.85
4.97%
Sold Out
0
-145,751
SAGE 		Sage Therapeutics Inc2024-07-31New Buy
+2.26%
●
10.38 ($11.5) 13.94
$7.85
-31.74%
New holding
557,004
557,004
XNCR 		Xencor Inc2024-07-31New Buy
+2.15%
●
18.18 ($21.24) 24.5
$21.16
-0.38%
New holding
283,973
283,973

Invesco Biotechnology & Genome ETF Total Holding History ($B)

To

Invesco Biotechnology & Genome ETF's Asset Allocation

To

Invesco Biotechnology & Genome ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2024-07-31

Invesco Biotechnology & Genome ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Invesco Biotechnology & Genome ETF's Holdings Heat Map

Size field:

Invesco Biotechnology & Genome ETF's Holdings Bubble Chart

Invesco Biotechnology & Genome ETF News

  • 1

Discussions on Invesco Biotechnology & Genome ETF

User's Avatar
How would you rate this stock? PBE
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.